Phosphoinositide-3-kinase Regulatory Subunit 1 Gene Polymorphisms Are Associated with Schizophrenia and Bipolar Disorder in the Han Chinese Population

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2020 Mar 21

PMID 32193760

Citations 6

Authors

Jiao Huang

Zhaoxia Chen

Lulu Zhu

Xulong Wu

Xiaojing Guo

Jialei Yang

Jianxiong Long

Li Su

Affiliations

Soon will be listed here.

Abstract

Schizophrenia (SCZ) and bipolar disorder (BD) are severe psychiatric disorders that share many genetic risk factors. This study aimed to investigate the association of phosphoinositide-3-kinase regulatory subunit1 (PIK3R1) gene rs3756668 and rs3730089 polymorphisms with SCZ and BD risks and determine the expression levels of PIK3R1. A total of 548 SCZ cases, 512 BD cases, and 598 healthy controls were included in this study. Single nucleotide polymorphisms (SNPs) were genotyped using the Sequenom MassARRAY platform, and quantitative reverse transcription polymerase chain reaction was conducted to examine the mRNA expression of PIK3R1. The genotypic distribution of rs3756668 in the BD group was significantly different from that in the healthy controls (P = 0.038). After adjustment for gender and age was made, rs3730089 was significantly associated with the risk of SCZ [AA/(AG + GG): OR = 2.25, P = 0.040; AA/GG: OR = 2.27, P = 0.038]. The SNP rs3756668 was associated with the susceptibility of BD (AA+GG/AG: OR = 0.73, P = 0.011) and the association remained after adjusting for gender and age. The mRNA level of PIK3R1 was significantly upregulated in patients with BD compared with that in the control group (P < 0.001). In terms of the diagnostic value of PIK3R1 for BD, the receiver operating characteristic curve analysis showed an area under the curve of 0.809 with 74.0% sensitivity and 73.9% specificity. PIK3R1 may be the shared susceptibility gene of SCZ and BD and may be a potential diagnostic biomarker for BD.

Citing Articles

Association between MAPK and PI3K/Akt signaling pathway-related gene polymorphisms and migraine.

Wang M, Gu Y, Meng S, Kang L, Yang J, Sun D Mol Genet Genomic Med. 2024; 12(8):e2503.

PMID: 39140707 PMC: 11323340. DOI: 10.1002/mgg3.2503.

Identification and discovery of imaging genetic patterns using fusion self-expressive network in major depressive disorder.

Pang M, Liu X, Hao X, Wang M, Xie C, Zhang L Front Neurosci. 2023; 17:1297155.

PMID: 38075264 PMC: 10702989. DOI: 10.3389/fnins.2023.1297155.

Incorporating multi-stage diagnosis status to mine associations between genetic risk variants and the multi-modality phenotype network in major depressive disorder.

Zhang L, Pang M, Liu X, Hao X, Wang M, Xie C Front Psychiatry. 2023; 14:1139451.

PMID: 36937715 PMC: 10017727. DOI: 10.3389/fpsyt.2023.1139451.

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning.

Yang Q, Xing Q, Yang Q, Gong Y Comput Struct Biotechnol J. 2022; 20:5054-5064.

PMID: 36187923 PMC: 9486057. DOI: 10.1016/j.csbj.2022.09.014.

Integrated co-expression network analysis uncovers novel tissue-specific genes in major depressive disorder and bipolar disorder.

Han M, Yuan L, Huang Y, Wang G, Du C, Wang Q Front Psychiatry. 2022; 13:980315.

PMID: 36081461 PMC: 9445988. DOI: 10.3389/fpsyt.2022.980315.

References

Alexandrov P, Zhao Y, Jaber V, Cong L, Lukiw W . Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders. Front Neurol. 2018; 8:670. PMC: 5732231. DOI: 10.3389/fneur.2017.00670. View

Almind K, Delahaye L, Hansen T, Van Obberghen E, Pedersen O, Kahn C . Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha. Proc Natl Acad Sci U S A. 2002; 99(4):2124-8. PMC: 122329. DOI: 10.1073/pnas.042688799. View

Beaulieu J, Gainetdinov R, Caron M . The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci. 2007; 28(4):166-72. DOI: 10.1016/j.tips.2007.02.006. View

Bowden N, Scott R, Tooney P . Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics. 2008; 9:199. PMC: 2386488. DOI: 10.1186/1471-2164-9-199. View

Bresee L, Majumdar S, Patten S, Johnson J . Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res. 2010; 117(1):75-82. DOI: 10.1016/j.schres.2009.12.016. View

Burghardt K, Seyoum B, Dass S, Sanders E, Mallisho A, Yi Z . Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. Pharmacotherapy. 2018; 38(4):428-435. PMC: 5999031. DOI: 10.1002/phar.2097. View

Castano-Betancourt M, Evans D, Ramos Y, Boer C, Metrustry S, Liu Y . Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis. PLoS Genet. 2016; 12(10):e1006260. PMC: 5049763. DOI: 10.1371/journal.pgen.1006260. View

Chen Y . Research Progress in the Pathogenesis of Alzheimer's Disease. Chin Med J (Engl). 2018; 131(13):1618-1624. PMC: 6032682. DOI: 10.4103/0366-6999.235112. View

Chen M, Gu J, Delclos G, Killary A, Fan Z, Hildebrandt M . Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis. 2010; 31(8):1387-91. PMC: 2915631. DOI: 10.1093/carcin/bgq110. View

10.

Chen C, Zhang C, Cheng L, Reilly J, Bishop J, Sweeney J . Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. Bipolar Disord. 2014; 16(8):790-9. PMC: 4302408. DOI: 10.1111/bdi.12255. View

11.

Emamian E, Hall D, Birnbaum M, Karayiorgou M, Gogos J . Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004; 36(2):131-7. DOI: 10.1038/ng1296. View

12.

Engelman J, Luo J, Cantley L . The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006; 7(8):606-19. DOI: 10.1038/nrg1879. View

13.

Goes F, Rongione M, Chen Y, Karchin R, Elhaik E, Potash J . Exonic DNA sequencing of ERBB4 in bipolar disorder. PLoS One. 2011; 6(5):e20242. PMC: 3102700. DOI: 10.1371/journal.pone.0020242. View

14.

Kolomeets N, Orlovskaya D, Rachmanova V, Uranova N . Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse. 2005; 57(1):47-55. DOI: 10.1002/syn.20153. View

15.

Krivosheya D, Tapia L, Levinson J, Huang K, Kang Y, Hines R . ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem. 2008; 283(47):32944-56. PMC: 5395083. DOI: 10.1074/jbc.M800073200. View

16.

Lichtenstein P, Yip B, Bjork C, Pawitan Y, Cannon T, Sullivan P . Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373(9659):234-9. PMC: 3879718. DOI: 10.1016/S0140-6736(09)60072-6. View

17.

Liu J, He J, Cheng M, Cao H, Zhang X . Prevalence, Sociodemographic, and Clinical Correlates of Older Chinese Patients With Deficit Schizophrenia. J Geriatr Psychiatry Neurol. 2019; 32(6):298-303. DOI: 10.1177/0891988719870321. View

18.

Long J, Huang G, Liang W, Liang B, Chen Q, Xie J . The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014; 130(4):244-56. DOI: 10.1111/acps.12296. View

19.

Malodobra M, Pilecka A, Gworys B, Adamiec R . Single nucleotide polymorphisms within functional regions of genes implicated in insulin action and association with the insulin resistant phenotype. Mol Cell Biochem. 2010; 349(1-2):187-93. DOI: 10.1007/s11010-010-0673-5. View

20.

Martin-Pena A, Acebes A, Rodriguez J, Sorribes A, de Polavieja G, Fernandez-Funez P . Age-independent synaptogenesis by phosphoinositide 3 kinase. J Neurosci. 2006; 26(40):10199-208. PMC: 6674615. DOI: 10.1523/JNEUROSCI.1223-06.2006. View